Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Computational Analysis of Immunohistochemistry Enables Quantitative Assessment of SARS-CoV-2 Nucleocapsid Immunolabeling in Experimentally Infected Mice.

Created on 27 Oct 2026

Authors

Nedim Kozarac, Marius Botos, Laura Burgener, Simone de Brot, Francisco Brito, Inês Berenguer Veiga, Adriano Taddeo, Christelle Devisme, Stefano Bagatella, Nadine Ebert, Güliz Tuba Barut, Étori Aguiar Moreira, Nathan George François Leborgne, Melanie Brügger, Volker Thiel, Charaf Benarafa, Llorenç Grau-Roma

Published in

Viruses. Volume 18. Issue 10. Oct 14, 2026. Epub Oct 14, 2026.

Abstract

Histopathology and immunohistochemistry (IHC) are central to COVID-19 tissue evaluation. However, conventional manual scoring is limited by its semiquantitative nature and potential observer variability. In this retrospective study of experimentally infected mice, we implemented a semi-automated digital pathology workflow using commercially available software to quantitatively assess SARS-CoV-2 nucleocapsid (N) immunolabeling in lung (n = 135) and brain (n = 67) tissues. The performance of digital quantification was evaluated against conventional manual scoring, and its association with virological and pathological parameters was assessed across different stages of disease progression. Digital IHC quantification demonstrated strong agreement with manual scoring in both lung [R = 0.94, p < 0.0001, concordance correlation coefficient (CCC) = 0.95] and brain [R = 0.98, p < 0.0001; CCC = 0.977], demonstrating concordance between the two approaches. In addition, digital SARS-CoV-2 N immunolabeling quantification showed significant positive correlations with viral RNA levels, infectious viral titers, and histopathological scores, supporting its association with independent measures of SARS-CoV-2 infection and lesions. Although computational image analysis requires additional infrastructure, technical expertise, and increased analysis time, it provides an objective continuous quantitative measure of SARS-CoV-2 N immunolabeling that complements conventional manual assessment and may reduce observer-dependent variability.

PMID:
42944061
Bibliographic data and abstract were imported from PubMed on 27 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 12
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement